Claremont BioSolutions

Claremont BioSolutions (ClaremontBio) is a developer of sample preparation and assay technologies for molecular diagnostics, medical applications, bio-defense testing, and primary research, that is based in Upland, California

ClaremontBio was established in 2006 as a spin-out company developing products based on research conducted at the Keck Graduate Institute in Claremont, California . The company was founded by three KGI faculty member: Robert Doebler, Ph.D., lecturer and director of the Marsh A. Cooper Bioengineering Laboratory; Jim Sterling, Ph.D., associate professor and director of the Team Masters Program; and Ali Nadim, Ph.D., professor. In 2008 Claremont BioSolutions licensed technologies from KGI to be used for the development of new sample preparation and diagnostic equipment and assays. In 2009 the company won a Phase I Small Business Innovation Research (SBIR) Grant from the NIH and was also selected for by the NIH to receive a technology “niche-assessment analysis".
Application areas
When ClaremontBio began developing its technology the technologies were developed for the rapid detection of bio-threats such as anthrax for the Department of Homeland Security. The company has since developed a line of products that can be used in performing diagnostic protocols. Examples include rapid cell lysis, nucleic acid purification, and His-tagged protein purification. ClaremontBio’s products are also currently used for sample preparation in the areas of life-science research, bio-threat detection, gene-sequencing, and in many other applications
< Prev   Next >